Table 2 PD-L1 evaluation of TC score, mIC score, and CPS.

From: Effector memory cytotoxic CD3+/CD8+/CD45RO+ T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer

 

ER-negative

ER/PR-low positive

Luminal

 

(n = 107)

(n = 28)

(n = 10)

PD-L1+ (≥1%)

 Tumour cells score

12

(11.2%)

2

(7.1%)

0

(0%)

 Modified immune cells score

31

(29.0%)

8

(28.6%)

0

(0%)

 CPS

33

(30.8%)

9

(32.1%)

0

(0%)

  1. Tumour cells (TC) score: PD-L1+ tumour cells/total tumour cells.
  2. Modified immune cells (mIC) score: PD-L1+ immune cells/total immune cells.
  3. Combined positive score (CPS): PD-L1+ tumour cells and immune cells/total tumour cells.
Back to article page